Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis

The binding of the tumor necrosis factor α (TNFα) to its cognate receptor initiates many immune and inflammatory processes. The drugs, etanercept (Enbrel(®)), infliximab (Remicade(®)), adalimumab (Humira(®)), certolizumab-pegol (Cimzia(®)), and golimumab (Simponi(®)), are anti-TNFα agents. These dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Heejin, Lee, Sang Hyung, Lee, Hyun Tae, Lee, Jee Un, Son, Ji Young, Shin, Woori, Heo, Yong-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877629/
https://www.ncbi.nlm.nih.gov/pubmed/29518978
http://dx.doi.org/10.3390/ijms19030768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877629/
https://www.ncbi.nlm.nih.gov/pubmed/29518978
http://dx.doi.org/10.3390/ijms19030768

Ejemplares similares